Journal
BIOMACROMOLECULES
Volume 8, Issue 10, Pages 3177-3183Publisher
AMER CHEMICAL SOC
DOI: 10.1021/bm700697a
Keywords
-
Funding
- NCI NIH HHS [R01 CA080163, CA080163, R01 CA080163-09] Funding Source: Medline
Ask authors/readers for more resources
Polyamine analogues show antitumor activity in experimental models, and their ability to alter activity of cytotoxic chemotherapeutic agents in breast cancer is well documented. Association of polyamines with nucleic acids and protein is included in their mechanism of action. The aim of this study was to examine the interaction of human serum albumin (HSA) with several polyamine analogues, such as 1,11-diamino-4,8-diazaundecane (333), 3,7,11,15-tetrazaheptadecane center dot 4HCl (BE-333), and 3,7,11,15,19-pentazahenicosane center dot 5HCl (BE-3333), in aqueous solution at physiological conditions using a constant protein concentration and various polyamine contents (mu M to mM). FTIR, UV-visible, and CD spectroscopic methods were used to determine the polyamine binding mode and the effects of polyamine complexation on protein stability and secondary structure. Structural analysis showed that polyamines bind nonspecifically (H-bonding) via polypeptide polar groups with binding constants of K-333 = 9.30 x 10(3) M-1, KBE-333 = 5.63 x 10(2) M-1, and KBE-3333 = 3.66 x 10(2) M-1. The protein secondary structure showed major alterations with a reduction of alpha-helix from 55% (free protein) to 43-50% and an increase of beta-sheet from 17% (free protein) to 29-36% in the 333, BE-333, and BE-3333 complexes, indicating partial protein unfolding upon polyamine interaction. HSA structure was less perturbed by polyamine analogues compared to those of the biogenic polyamines.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available